A Study to Test How Well Healthy People Tolerate Spesolimab When Given in 2 Different Ways
Clinical trial NCT06520514 · COMPLETED
Trial details
- NCT number
- NCT06520514
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-07
- Primary completion
- 2025-01-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.